TagsHER2

Tag: HER2

Healthcare

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast...

Ravindra Soni - May 28, 2026 0

Healthcare

U.S. FDA Grants Priority Review to BeOne Medicines' TEVIMBRA in First-Line HER2+ GEA

Ravindra Soni - April 29, 2026 0

Healthcare

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast...

Ravindra Soni - December 9, 2025 0

Healthcare

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with...

Ravindra Soni - November 26, 2024 0

Most Read

PL Capital forecasts mixed Q2FY27 earnings trends across Indian sectors

October 12, 2026

Zomato and Blinkit release ‘Main Udega’ anthem for delivery partners

October 12, 2026

MP Kamaljeet Sehrawat urges youth to avoid e-cigarettes, backs enforcement of nicotine ban

October 12, 2026

Cars24 delivers 750 cars on first day of Navratri, 58% rise year-on-year

October 12, 2026